BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6195795)

  • 1. [Chemotherapy of bladder tumors. Indications and value of loco-regional and systemic application].
    Pavone-Macaluso M
    Urologe A; 1983 Sep; 22 Suppl():325-31. PubMed ID: 6195795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical treatment of urothelial tumors of the bladder].
    Ferrière JP; Dionet C; Dauplat J; Boiteux JP; Plagne R; Giraud B
    Ann Urol (Paris); 1988; 22(4):229-34. PubMed ID: 3056230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bladder cancer with intravesical instillation of adriamycin.
    Pavone-Macaluso M; Ingargiola GB; Tripi M; Lamartina M
    Prog Clin Biol Res; 1984; 162B():181-91. PubMed ID: 6390445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
    Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
    J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer.
    Feneley MR; Mellon JK
    Semin Urol Oncol; 2000 Nov; 18(4):300-7. PubMed ID: 11101094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravesical chemotherapy in superficial tumors of the bladder].
    Lundbeck F
    Ugeskr Laeger; 1983 Feb; 145(9):641-4. PubMed ID: 6857826
    [No Abstract]   [Full Text] [Related]  

  • 9. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of bladder cancer: a review.
    Smith PH
    Cancer Treat Rep; 1981; 65 Suppl 1():165-73. PubMed ID: 6799197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials.
    Sylvester RJ; van der Meijden AP; Witjes JA; Kurth K
    J Urol; 2005 Jul; 174(1):86-91; discussion 91-2. PubMed ID: 15947584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.
    Serretta V; Lo Greco G; Pavone C; Pavone-Macaluso M
    J Urol; 1998 Apr; 159(4):1187-91. PubMed ID: 9507829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in the internist treatment of bladder tumors].
    Baumgartner G
    Wien Med Wochenschr; 1982 Jul; 132(13-14):305-12. PubMed ID: 6814073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
    Bex A; Nieuwenhuijzen JA; Kerst M; Pos F; van Boven H; Meinhardt W; Horenblas S
    Urology; 2005 Feb; 65(2):295-9. PubMed ID: 15708041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravesical instillation of adriamycin and other antineoplastic agents].
    Matsumura Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):372-6. PubMed ID: 7184406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.